EUR/USD 1.1533 ▼ 0.16%GBP/USD 1.3471 ▼ 0.23%USD/JPY 154.8836 ▲ 0.35%USD/CHF 0.8174 ▼ 0.00%EUR/CHF 0.9437 ▼ 0.05%BTC/USD 77,630.01 ▼ 0.72%ETH/USD 2,495.09 ▼ 0.82%SOL/USD 100.87 ▼ 1.62%XAU/USD 4,291.03 ▼ 0.17%EUR/USD 1.1533 ▼ 0.16%GBP/USD 1.3471 ▼ 0.23%USD/JPY 154.8836 ▲ 0.35%USD/CHF 0.8174 ▼ 0.00%EUR/CHF 0.9437 ▼ 0.05%BTC/USD 77,630.01 ▼ 0.72%ETH/USD 2,495.09 ▼ 0.82%SOL/USD 100.87 ▼ 1.62%XAU/USD 4,291.03 ▼ 0.17%
Finance Review DailyMARKETS • BUSINESS • ECONOMY
DERNIÈRE MINUTE
Oil Prices Surge Over 4% to 16-Week High on Saudi Strikes and Gulf-Tensions•Federal Reserve expected to raise rates under Chairman Kevin Warsh as oil tops $100 a barrel•Zevra Therapeutics Sees Rare-Disease Market as $30M+ Per-Quarter Opportunity•Loonie Holds Near 12-Day Low as Oil Support Fails to Offset Dollar Strength•Radiant Logistics Q4 Earnings Top Estimates, Shares Jump 6.8%•Oil Prices Surge Over 4% to 16-Week High on Saudi Strikes and Gulf-Tensions•Federal Reserve expected to raise rates under Chairman Kevin Warsh as oil tops $100 a barrel•Zevra Therapeutics Sees Rare-Disease Market as $30M+ Per-Quarter Opportunity•Loonie Holds Near 12-Day Low as Oil Support Fails to Offset Dollar Strength•Radiant Logistics Q4 Earnings Top Estimates, Shares Jump 6.8%•
ADVERTISEMENT
DESK EN DIRECT·Rédaction marchés mondiaux·Last updated 14s ago
ADVERTISEMENT
Entreprises/RésultatsArticle

PMV Pharma at H.C. Wainwright: rezafapt nears pivotal test

PMV Pharma highlighted that its rezafapt candidate is approaching a pivotal test during an H.C. Wainwright briefing.

PA
Priya Anand · Equities & Earnings Desk · 15 Sept 2026 · 06:47 · 1 min de lecture
Partager
PMV Pharma at H.C. Wainwright: rezafapt nears pivotal test

During an H.C. Wainwright session, PMV Pharma indicated that its experimental drug rezafapt is nearing a pivotal test.

No further details were disclosed at the time.

Earnings
Cet article a été produit avec l'assistance de l'IA et édité par un journaliste de Finance Review Daily.
ADVERTISEMENT
Partager cet article
PA
Par
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

Plus de Priya Anand →
ADVERTISEMENT

Aperçu du marché

Différé
EUR/USD1.1533▼ 0.16%GBP/USD1.3471▼ 0.23%USD/CHF0.8174▼ 0.00%BTC/USD77,630.01▼ 0.72%ETH/USD2,495.09▼ 0.82%XAU/USD4,291.03▼ 0.17%

À lire aussi

Kistos reports $205m pro-forma H1 EBITDA, completes Oman Blocks 3&4 deal
Résultats

Kistos reports $205m pro-forma H1 EBITDA, completes Oman Blocks 3&4 deal

Priya Anand · il y a 24 min
ADVERTISEMENT